Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USP Botanical Advisory Panel Will Address Non-Monograph Standards

This article was originally published in The Tan Sheet

Executive Summary

A new U.S. Pharmacopeia advisory panel will seek to set standards on a range of topics not covered in USP's botanical monographs, such as optimal standards for the growth, handling and harvesting of botanical ingredients

You may also be interested in...



Nature’s Resource Labeling To Spell Out ABCs Of Supplement Information

Pharmavite and the American Botanical Council are teaming up to develop new labeling for the Nature's Resource line of supplements, the groups announced at the National Association of Chain Drug Stores Marketplace 2002 in San Diego June 16-18

USP Quality Demonstration Program "Supplements" Monograph Development

The U.S. Pharmacopeia's new draft proposal, Quality Demonstration Program for Dietary Supplements, will complement the group's ongoing monograph development.

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS094888

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel